Three independent discounted-cash-flow-style models value Collegium Pharmaceutical, Inc. Common Stock every trading day. 0 of 3 currently price COLL above its market price.
| Free Cash Flow model | $16.00 |
| Excess Profit model | $-189.76 |
| Residual Earnings model | $10.98 |
| Dividend Discount model | — |
| Piotroski F-Score | 7 / 9 |
| Return on invested capital | +11.7% |
| Net debt / EBITDA | 5.1× |
| Gross margin | +59.3% |
| Revenue CAGR | +41.3% |
| Cash conversion | 5.2× |
| Dividend yield | — |
| Buyback yield | +6.0% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open COLL in StockKitty